Compare AU
Compare SUBD vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Aussie Subordinated Bonds (SUBD) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
SUBD | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 18 | 63 |
Median incremental investment | $4,011.00 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $10,878.12 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Key Summary
SUBD | DRUG | |
|---|---|---|
Strategy | SUBD.AX was created on 2019-10-28 by VanEck. The fund's investment portfolio concentrates primarily on investment grade fixed income. SUBD.AX invests in a portfolio of subordinated bonds with the aim of providing investment returns before fees and other costs that track the performance of the Index. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Commonwealth Bank of Australia (8.90 %) National Australia Bank Ltd. (7.15 %) ANZ Group Holdings Ltd. (6.31 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.29 % | 0.57 % |
Key Summary
SUBD | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | iBoxx AUD Investment Grade Subordinated Debt Mid Price Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.29 % | 0.57 % |
Price | $25.21 | $8.12 |
Size | $2.088 billion | $191.120 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 3.58 % | 1.90 % |
Market | ASX | ASX |
First listed date | 30/10/2019 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
SUBD | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 18 | 63 |
Median incremental investment | $4,011.00 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $10,878.12 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
SUBD | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
SUBD | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |